This trial will test whether earlier vaccination for HPV will result in less parental refusal and higher rates of full vaccination.
1 Primary · 2 Secondary · Reporting Duration: post-intervention assessed in year 5 of study, year 4 of trial
Active Control
Experimental Treatment
660 Total Participants · 2 Treatment Groups
Primary Treatment: (Intervention) Recommending HPV vaccine for patients 9-10 years of age · No Placebo Group · N/A
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: